Global Pain Management Medicines Market was Valued at US$ 63,212.3 Mn in 2017 and is Predicted to Grow at a Strong CAGR of 3.9% from 2018 to 2026

-

Pain management medications are a family of drugs with pharmacological effects on pain receptors that work to alleviate pain feelings. Opioids, non-steroidal anti-inflammatory medicines (NSAIDs), anticonvulsants, antidepressants, muscle relaxants, and other pharmaceuticals are among them. These drugs can be used to treat pain for a variety of diseases, as mentioned on the label, and some have off-label uses. Anticonvulsants and antidepressants, for example, were developed to treat epilepsy and depression, respectively.

There are no other options for treatment. Over the forecast period, therapies are expected to fuel the growth of the Pain Management Medicines Market. Janssen Pharmaceuticals, Inc. sold Depomed, Inc. the rights to NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) extended-release tablets, and NUCYNTA (tapentadol) oral solution in the United States in 2015. Tapentadol comes in pill, solution, and extended-release formulations. Furthermore, NUCYNTA owns three patents for tablet and solution forms, one of which expired in June 2017 and the other two of which will expire in June 2025 and August 2029, respectively. Furthermore, the patent expiration of pain management pharmaceuticals such as Oxycontin, Opana, Celebrex (2013-2014), and others are presenting market competitors with an opportunity to introduce new products into the pain management drugs market.

Furthermore, manufacturers such as Pfizer, Inc. are introducing novel drug delivery systems such as prefilled syringes and injectable doses, which is projected to fuel the Pain Management Medicines Market Growth throughout the forecast period. Manufacturers offer a wide selection of products in capsule and tablet form, including generic and branded medications. Furthermore, when compared to pain therapies such as invasive approaches and physiotherapy, some of the medicines are a more cost-effective choice. Over the forecast term, these factors are expected to promote market growth even more.

Over the forecast period, the high prevalence of chronic pain illnesses is expected to fuel the expansion of the Pain Management Medicines Market. According to the American Academy of Pain Medicine, 1.8 billion individuals worldwide experienced chronic pain in 2011. Furthermore, according to the National Institutes of Health (NIH), one out of every ten adults in the United States suffers from chronic pain. According to a 2016 study published in the British Medical Journal, chronic pain affects about one-third to half of the population in the United Kingdom. Furthermore, around 50 million people in the United States suffer from chronic pain, according to NIH estimates published in 2015 by the American Pain Society.

Comments

Post a Comment

Popular posts from this blog

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f...
Read more

Endometrial Ablation Market Analysis, Industry Scope, Global Opportunity Analysis and Forecast Till 2027

-
Image
Endometrial Ablation Market Endometrial ablation is a procedure used to treat abnormally high uterine bleeding that cannot be managed by medicine by facilitating the destruction of the endometrium, a thin layer of the uterine wall. According to the American College of Obstetrics and Gynecology, Endometrial Ablation Market is not indicated for women who have endometrial diseases, endometrial hyperplasia, uterine cancer, a recent pregnancy, and specific uterine infections (ACOG). There are various endometrial ablation procedures available, including radiofrequency, heated fluid, heated balloon, electrosurgery, freezing, and microwave ablation techniques, depending on the technique and kind of patient being treated. The easy access to recently developed sophisticated ablation technology, convenience of use, shorter treatment times, and outpatient facilities, North America dominates the Endometrial Ablation Market . Endometrial ablation devices would see a sharp rise in global adoption d...
Read more

Blowing Agents Market Top Companies, Trends & Growth Factors, and Trend Forecast to 2025

-
Image
Blowing Agents Market The Blowing Agents Market is experiencing substantial growth, driven by the expanding demand from various industries such as construction, automotive, and packaging. Blowing agents are essential in foam production processes, contributing to lightweight and energy-efficient materials. Key market players are continuously investing in research and development to introduce eco-friendly and efficient blowing agents. The rising awareness regarding environmental concerns has led to the adoption of low global warming potential (GWP) and zero ozone depletion potential (ODP) blowing agents. Additionally, stringent regulations and policies promoting sustainable manufacturing practices have further accelerated the demand for environmentally friendly blowing agents. The market is witnessing a trend toward the adoption of innovative technologies to improve production efficiency and product performance. Advanced nucleating agents and microcellular foaming technologies are enhan...
Read more